Bought
Maintained
Sold
Other funds holding GSK
UBS Group's GSK Position: Q3 2026 in Review
UBS Group reduced its GSK (GSK) stake by 22% in Q3 2026, selling an estimated $32.2M and leaving 2,175,708 shares worth $105M. The position accounts for 0.01% of the portfolio, ranked #1063.
UBS Group first reported a position in GSK in Q4 2014 and has held it in 48 quarters since. The position peaked at $308M in Q4 2025. 913 funds tracked by Wall St. Rank hold GSK as of Q3 2026.
- UBS Group held 2,175,708 shares of GSK worth $105M as of Q3 2026.
- UBS Group sold 630,497 GSK shares in Q3 2026, an estimated $32.2M.
- GSK made up 0.01% of UBS Group's portfolio in Q3 2026, its #1063 holding.
- UBS Group first reported a position in GSK in Q4 2014 and has held it in 48 quarters since.
- UBS Group's GSK position peaked at $308M in Q4 2025.
- 913 funds tracked by Wall St. Rank held GSK as of Q3 2026.
Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.